{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:56:37Z","timestamp":1787644597236,"version":"build-2736575974"},"reference-count":45,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/br.2017.851","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T08:06:16Z","timestamp":1485504376000},"page":"267-271","source":"Crossref","is-referenced-by-count":22,"title":["Chemotherapy-induced peripheral neuropathy"],"prefix":"10.3892","volume":"6","author":[{"given":"Xia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"key20180107142655_b1-br-0-0-851","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMc1511702","article-title":"A mechanism for cancer-associated membranous nephropathy","volume":"374","author":"Hoxha","year":"2016","journal-title":"N Engl J Med"},{"key":"key20180107142655_b2-br-0-0-851","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JOP.2014.001386","article-title":"The state of cancer care in America, 2014: A report by the American Society of Clinical Oncology","volume":"10","year":"2014","journal-title":"J Oncol Pract"},{"key":"key20180107142655_b3-br-0-0-851","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: Prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107142655_b4-br-0-0-851","year":"2014","journal-title":"Chemotherapy side effects sheets"},{"key":"key20180107142655_b5-br-0-0-851","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1526-4637.2001.002001008.x","article-title":"Chemotherapy-evoked painful peripheral neuropathy","volume":"2","author":"Polomano","year":"2001","journal-title":"Pain Med"},{"key":"key20180107142655_b6-br-0-0-851","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"American Society of Clinical Oncology: Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20180107142655_b7-br-0-0-851","first-page":"352","article-title":"Anesthetic management with propofol alone in a patient with hereditary sensory and autonomic neuropathy","volume":"65","author":"Fujita","year":"2016","journal-title":"Masui"},{"key":"key20180107142655_b8-br-0-0-851","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanisms of disease: Neuropathic pain - a clinical perspective","volume":"2","author":"Baron","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"key20180107142655_b9-br-0-0-851","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: Emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat Neurosci"},{"key":"key20180107142655_b10-br-0-0-851","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J Med Genet"},{"key":"key20180107142655_b11-br-0-0-851","doi-asserted-by":"crossref","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function Nav1.8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20180107142655_b12-br-0-0-851","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ana.10364","article-title":"Changes of sodium channel expression in experimental painful diabetic neuropathy","volume":"52","author":"Craner","year":"2002","journal-title":"Ann Neurol"},{"key":"key20180107142655_b13-br-0-0-851","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1523\/JNEUROSCI.0242-04.2004","article-title":"Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat","volume":"24","author":"Alessandri-Haber","year":"2004","journal-title":"J Neurosci"},{"key":"key20180107142655_b14-br-0-0-851","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1046\/j.0953-816x.2001.01591.x","article-title":"VR1 protein expression increases in undamaged DRG neurons after partial nerve injury","volume":"13","author":"Hudson","year":"2001","journal-title":"Eur J Neurosci"},{"key":"key20180107142655_b15-br-0-0-851","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0301-0082(99)00051-9","article-title":"Wind-up of spinal cord neurones and pain sensation: Much ado about something?","volume":"61","author":"Herrero","year":"2000","journal-title":"Prog Neurobiol"},{"key":"key20180107142655_b16-br-0-0-851","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion (\u03b1)2(\u03b4) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats","volume":"21","author":"Luo","year":"2001","journal-title":"J Neurosci"},{"key":"key20180107142655_b17-br-0-0-851","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1523\/JNEUROSCI.22-15-06724.2002","article-title":"Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord","volume":"22","author":"Moore","year":"2002","journal-title":"J Neurosci"},{"key":"key20180107142655_b18-br-0-0-851","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nature01868","article-title":"Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain","volume":"424","author":"Coull","year":"2003","journal-title":"Nature"},{"key":"key20180107142655_b19-br-0-0-851","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/1058-9139(92)90030-G","article-title":"Is there a facilitating component to central pain modulation?","volume":"1","author":"Fields","year":"1992","journal-title":"APS J"},{"key":"key20180107142655_b20-br-0-0-851","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tins.2012.06.002","article-title":"Pain-related changes in the brain: diagnostic and therapeutic potentials","volume":"35","author":"Saab","year":"2012","journal-title":"Trends Neurosci"},{"key":"key20180107142655_b21-br-0-0-851","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/bja\/75.2.125","article-title":"Inflammatory mediators of pain","volume":"75","author":"Dray","year":"1995","journal-title":"Br J Anaesth"},{"key":"key20180107142655_b22-br-0-0-851","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1742-2094-8-110","article-title":"Wallerian degeneration: Gaining perspective on inflammatory events after peripheral nerve injury","volume":"8","author":"Gaudet","year":"2011","journal-title":"J Neuroinflammation"},{"key":"key20180107142655_b23-br-0-0-851","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1359-6446(05)03637-8","article-title":"The role of neuroinflammation in neuropathic pain: Mechanisms and therapeutic targets","volume":"11","author":"Myers","year":"2006","journal-title":"Drug Discov Today"},{"key":"key20180107142655_b24-br-0-0-851","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0022-510X(91)90162-Z","article-title":"The role of complement in myelin phagocytosis during PNS wallerian degeneration","volume":"103","author":"Br\u00fcck","year":"1991","journal-title":"J Neurol Sci"},{"key":"key20180107142655_b25-br-0-0-851","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1213\/01.ANE.0000055362.56604.78","article-title":"The role of interleukin-6 in nociception and pain","volume":"96","author":"De Jongh","year":"2003","journal-title":"Anesth Analg"},{"key":"key20180107142655_b26-br-0-0-851","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(99)00450-4","article-title":"Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy","volume":"270","author":"Sommer","year":"1999","journal-title":"Neurosci Lett"},{"key":"key20180107142655_b27-br-0-0-851","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/ACO.0b013e32830eb69d","article-title":"Chemokines as pain mediators and modulators","volume":"21","author":"White","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"key20180107142655_b28-br-0-0-851","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: Is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"key":"key20180107142655_b29-br-0-0-851","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/leu.2011.346","article-title":"Management of treatment-emergent peripheral neuropathy in multiple myeloma","volume":"26","author":"Richardson","year":"2012","journal-title":"Leukemia"},{"key":"key20180107142655_b30-br-0-0-851","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180107142655_b31-br-0-0-851","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","article-title":"Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib","volume":"24","author":"Richardson","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107142655_b32-br-0-0-851","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3324\/haematol.2009.012674","article-title":"Peripheral neuropathy and new treatments for multiple myeloma: Background and practical recommendations","volume":"95","author":"Mohty","year":"2010","journal-title":"Haematologica"},{"key":"key20180107142655_b33-br-0-0-851","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3111\/13696998.2015.1115407","article-title":"Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma","volume":"19","author":"Usmani","year":"2016","journal-title":"J Med Econ"},{"key":"key20180107142655_b34-br-0-0-851","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jpain.2011.04.008","article-title":"Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients","volume":"12","author":"Boyette-Davis","year":"2011","journal-title":"J Pain"},{"key":"key20180107142655_b35-br-0-0-851","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","article-title":"Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats","volume":"14","author":"Meregalli","year":"2010","journal-title":"Eur J Pain"},{"key":"key20180107142655_b36-br-0-0-851","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp Neurol"},{"key":"key20180107142655_b37-br-0-0-851","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12640-009-9086-1","article-title":"Bortezomib induces the formation of nuclear poly(A) RNA granules enriched in Sam68 and PABPN1 in sensory ganglia neurons","volume":"17","author":"Casafont","year":"2010","journal-title":"Neurotox Res"},{"key":"key20180107142655_b38-br-0-0-851","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Windebank","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"key20180107142655_b39-br-0-0-851","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107142655_b40-br-0-0-851","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7556\/jaoa.2005.105.2.71","article-title":"Evaluating the patient with peripheral nervous system complaints","volume":"105","author":"Scott","year":"2005","journal-title":"J Am Osteopath Assoc"},{"key":"key20180107142655_b41-br-0-0-851","year":"2014","journal-title":"Highlights of prescribing information"},{"key":"key20180107142655_b42-br-0-0-851","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrneurol.2010.160","article-title":"Chemotherapy-induced peripheral neurotoxicity","volume":"6","author":"Cavaletti","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"key20180107142655_b43-br-0-0-851","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/A:1008345613594","article-title":"Grading of chemotherapy-induced peripheral neuropathy","volume":"11","author":"Postma","year":"2000","journal-title":"Ann Oncol"},{"key":"key20180107142655_b44-br-0-0-851","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","article-title":"Total neuropathy score: Validation and reliability study","volume":"53","author":"Cornblath","year":"1999","journal-title":"Neurology"},{"key":"key20180107142655_b45-br-0-0-851","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pain.2010.05.002","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes","volume":"150","author":"Maier","year":"2010","journal-title":"Pain"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/br.2017.851\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T21:29:40Z","timestamp":1568755780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2017.851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,1,27]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/br.2017.851"],"URL":"https:\/\/doi.org\/10.3892\/br.2017.851","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}